Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT03901521

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study will analyze the germline and somatic mutations underlying the development of ADPKD in order to better understand the genetic mechanism responsible for the cystic transformation. Once identified, these mutations could help us understand better the mechanism leading to the development of this disease and may explain at least in part the phenotypic variability.

Detailed description

The presentation of ADPKD renal and extrarenal manifestations varies widely, even within families, and has been attributed to numerous genetic factors. One principal explanation came with the discovery that renal cyst lining cells from ADPKD patients undergo secondary somatic mutations, selective loss of the second copy of a respective normal polycystic kidney disease (PKD) gene. These somatic mutations can occur in either polycystic kidney disease 1 (PKD1) or polycystic kidney disease 2 (PKD2). Furthermore, various cysts in the same patient have been reported to harbor different somatic mutations. These findings implicated a cellular recessive mechanism for cyst formation in ADPKD, suggesting the possibility that the observed intra-familial variation in disease phenotype may, at least in part, be explained by variation in mutation type, the timing and number of somatic "second-hit" mutations in individual family members affected with the disease. However, there is currently very little known about the cellular genetic mechanism leading to cysts development and very few studies, addressing this issue.

Conditions

Timeline

Start date
2018-06-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2019-04-03
Last updated
2026-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03901521. Inclusion in this directory is not an endorsement.